Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

First Horizon Receives Positive Ratings and Prepares for Barclays Global Financial Services Conference

Elaine Mendonca by Elaine Mendonca
March 8, 2024
in Breaking News
0
Investings on laptop and finances
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

Jared Shaw, an analyst at Barclays, has recently started covering First Horizon (NYSE:FHN) with an optimistic rating of Overweight and a target price of $18. This follows Citigroup’s endorsement of First Horizon with a “buy” rating and a target price of $14.00.

In other news, First Horizon Corporation is gearing up to take part in the Barclays Global Financial Services Conference. The company’s Chairman, President, and CEO, Bryan Jordan, is expected to deliver a speech on September 12, 2023.

FHN Stock Shows Positive Momentum on March 8, 2024 with Uptrend and Buying Interest

On March 8, 2024, FHN stock showed positive momentum as it traded in the middle of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been performing relatively well compared to its historical prices and is currently in an uptrend.

The price of FHN shares increased by $0.08 since the market last closed, representing a 0.53% rise. The stock opened at $15.19, which was $0.20 higher than its previous close. This suggests that there was buying interest in the stock at the opening bell, pushing the price higher right from the start of the trading day.

FHN Stock Analysis: Strong Financial Performance and Promising Growth Potential

On March 8, 2024, FHN stock showed promising performances based on the financial data provided by CNN Money. The total revenue for FHN stood at $4.78 billion for the past year, with a significant increase of 38.64% compared to the previous year. However, the total revenue remained flat since the last quarter at $1.26 billion.

The net income for FHN was reported at $897.00 million for the past year, showing no change since the previous year. However, there was a notable increase of 34.31% in net income since the last quarter, reaching $184.00 million.

Furthermore, the earnings per share (EPS) for FHN were $1.54 for the past year, which remained unchanged from the previous year. However, there was a substantial increase of 36.51% in EPS since the last quarter, reaching $0.31.

Overall, FHN stock demonstrated positive growth in net income and EPS since the last quarter, indicating a strong performance in the financial aspect. The increase in total revenue since the previous year also reflects the company’s ability to generate more revenue over time.

Investors and analysts may view these financial indicators as positive signs for FHN stock, suggesting potential growth and profitability in the future. It is essential to monitor the company’s financial performance continuously to make informed investment decisions based on the latest data and market trends.

Tags: FHN
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Technology Data analytics Stock Exchange

Elon Musk Endorses Fallout Series at SXSW Event

Biotechnology Trading online

Entera Bios Fiscal Year 2023 Financial Highlights and Cost Management Strategy

Technology Blockchain Markets and money

Title Ainos Inc Reports Significant Drop in Revenue for Fiscal Year 2023

Recommended

Jakks Pacific Reports Disappointing Q4 2023 Earnings

2 years ago
Ecommerce Stock Exchange

Notable Options Market Activity for Shopify

2 years ago
Fannie Mae Stock

Fannie Mae’s Public Offering Plans Derailed by Prominent Investor

3 months ago
Ocugen Stock

Ocugen Shares Face Critical Test Amid Steep Decline

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Tellurian Acquisition Finalized as Woodside Takes Control

Coherus BioSciences Forges Key Oncology Alliance with Janssen

TCG BDC Investors Await Key Financial Milestones

Trending

Viking Therapeutics Stock
Earnings

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

by Rodolfo Hanigan
February 7, 2026
0

Investors in Viking Therapeutics are currently focused on a specific calendar event rather than breaking news. The...

Diginex Stock

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026
Deluxe Stock

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Hydrofarm Holdings Inc Stock

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026
Northeast Bancorp Stock

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

February 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment
  • Diginex Enters Critical Implementation Phase Following Strategic Moves
  • Deluxe Stock Gains Momentum on Successful Fintech Transition

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com